Article: GenStar, Vascular Genetics To Form Autus, Combine Focuses.

Senior Staff Writer

Vascular Genetics Inc. and GenStar Therapeutics Corp. are merging to form Autus Genetics Corp., a company that will focus on the lead products of both of its parts. The merger was born out of a conversation between the two heads of the companies early this year.

"[GenStar CEO] Bob Sobol and I met in January and discussed some mutually beneficial activities that would help both companies," Richard Otto, CEO of VGI, told BioWorld Today, adding they soon had a second meeting. "We started thinking, What if we decided to get together?' Where we are today is based on those initial discussions."

The deal will be completed through a ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!